The Bav­arian research com­pany ISAR Bioscience is well on the way to a new Alzheimer’s therapy.

ISAR Bioscience has been gran­ted a man­u­fac­tur­ing author­isa­tion in accord­ance with the Ger­man Medi­cines Act (§13 AMG) and a GMP (Good Man­u­fac­tur­ing Prac­tice) cer­ti­fic­a­tion for its facil­ity in Planegg near Munich.

In the cooper­a­tion pro­ject with the Uni­ver­sity of Munich, cell cul­ture mod­els will be cre­ated for the devel­op­ment of novel drug therapies.

The European Innov­a­tion Coun­cil (EIC) has announced the selec­tion of pro­pos­als from the 2023 EIC Pathfinder Open call, which funds ideas for new break­through technologies.

Sci­ent­ists of the BASE-Lipid con­sor­tium met for two days at Evonik’s Hanau site to fur­ther coordin­ate their joint research.

The Ger­man Fed­eral Min­istry of Eco­nom­ics and Cli­mate Pro­tec­tion (BMWK) will be fund­ing a future-ori­ented pro­ject coordin­ated by ISAR Bioscience to invest­ig­ate and develop effi­cient and safe poly­mer-based spe­cial lip­ids for RNA drugs.

ISAR Bioscience is part of the doc­toral pro­gram “RNAmed”, which is fun­ded by the Elite Net­work Bavaria.

The Super­vis­ory Board of ISAR Bioscience has exten­ded the con­tract with Pro­fessor Lohse as Man­aging Dir­ector (Chair­man) for another five years.

A research team led by Martin Lohse has dis­covered that a pro­tein called RAMP can speed up recept­ors. The mech­an­ism could provide a new tar­get for drugs.

The Ger­man Fed­eral Min­istry of Edu­ca­tion and Research (BMBF) has selec­ted the win­ners of the second round of the Clusters4Future competition.

The Uni­ver­sity of Glasgow has awar­ded an hon­or­ary doctorate of sci­ence, DSc, to the head of ISAR Bioscience on the occa­sion of its Com­mem­or­a­tion Day.

A research team led by Martin Lohse has now shown how a cell can pro­cess hun­dreds of sig­nals sim­ul­tan­eously. The new res­ults, pub­lished in the pres­ti­gi­ous journal “Cell”, will open up a com­pletely new field of research in cell biology.

Fight­ing autoim­mune dis­eases and can­cer with human immune cells more effi­ciently: medi­cine is mov­ing a step closer to this vis­ion with new pro­cesses developed by ISAR Bioscience GmbH

The Ger­man Fed­eral Min­istry of Edu­ca­tion and Research (BMBF) has announced the win­ners in the com­pet­i­tion for new ther­apies against Covid-19. At the fore­front is the joint pro­ject of rnat­ics, a spin-off of the Tech­nical Uni­ver­sity of Munich (TUM), and ISAR Bioscience. 

Corona research: BfArM gives green light for further development into a therapy against COVID-19

Dr Chris­ti­ane Schiegerl took over as Head of Admin­is­tra­tion on 1 August 2021. She suc­ceeds Johanna Boeck-Heuwinkel, who is now Chan­cel­lor of the Düs­sel­dorf Art Academy. 

ISAR Bioscience contributes to the fight against the pandemic: Research project on the diagnosis of SARS-CoV2 antibodies.